| O.1 | Approve Financial Statements and Statutory Reports
| Oppose |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports
| Oppose |
| O.3 | Approve Allocation of Income and Dividends of EUR 1.43 per Share
| For |
| O.4 | Approve Compensation Report of Corporate Officers
| Oppose |
| O.5 | Approve Compensation of Denis Duverne, Chairman of the Board
| For |
| O.6 | Approve Compensation of Thomas Buberl, CEO
| Oppose |
| O.7 | Approve Amendment of Remuneration Policy of CEO
| Oppose |
| O.8 | Approve Remuneration Policy of CEO
| Oppose |
| O.9 | Approve Remuneration Policy of Chairman of the Board
| For |
| O.10 | Approve Remuneration Policy of Directors
| For |
| O.11 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions
| For |
| O.12 | Elect Ramon De Oliveira - Non-Executive Director | Oppose |
| O.13 | Elect Guillaume Faury - Non-Executive Director | For |
| O.14 | Elect Ramon Fernandez - Non-Executive Director | For |
| O.15 | Authorise Share Repurchase | Oppose |
| E.16 | Authorize Capitalization of Reserves of Up to EUR 1 Billion for Bonus Issue or Increase in Par Value
| For |
| E.17 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 2 Billions
| For |
| E.18 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 550 Million
| Oppose |
| E.19 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 550 Million
| Oppose |
| E.20 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights
| Oppose |
| E.21 | Authorize Capital Increase of Up to EUR 550 Million for Future Exchange Offers
| For |
| E.22 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| For |
| E.23 | Authorize Issuance of Equity Upon Conversion of a Subsidiary's Equity-Linked Securities without Preemptive Rights for Up to EUR 550 Million
| Oppose |
| E.24 | Authorize Issuance of Equity Upon Conversion of a Subsidiary's Equity-Linked Securities with Preemptive Rights for Up to EUR 2 Billion
| For |
| E.25 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans
| Oppose |
| E.26 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees of International Subsidiaries
| Oppose |
| E.27 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
| For |
| E.28 | Authorize Filing of Required Documents/Other Formalities
| For |
